Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Schrodinger, Inc. - Common Stock
(NQ:
SDGR
)
17.98
+0.10 (+0.56%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Schrodinger, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
3 Momentum Stocks That Could Soar Post-Market Volatility
April 21, 2025
Three unexpected companies have rallied quickly in the period following tariff-related market turbulence; can they maintain momentum?
Via
MarketBeat
Topics
Artificial Intelligence
World Trade
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 18, 2025
From
Schrödinger
Via
Business Wire
Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
April 14, 2025
From
Schrödinger
Via
Business Wire
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
↗
April 14, 2025
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.
Via
Benzinga
Topics
Animal Testing
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
↗
April 11, 2025
Via
Benzinga
Wondering what's happening in today's after-hours session?
↗
April 10, 2025
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements
↗
April 10, 2025
Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing...
Via
Benzinga
Topics
Animal Testing
Schrödinger to Present Preclinical Data at AACR Annual Meeting
March 25, 2025
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 18, 2025
From
Schrödinger
Via
Business Wire
Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen
March 10, 2025
From
Schrödinger
Via
Business Wire
Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results
February 26, 2025
From
Schrödinger
Via
Business Wire
Schrödinger to Participate in Upcoming Investor Conferences
February 24, 2025
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 20, 2025
From
Schrödinger
Via
Business Wire
Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26
February 12, 2025
From
Schrödinger
Via
Business Wire
AI Pharma: 2 Paths to AI-Powered Drug Investment
January 28, 2025
AI is transforming drug development, allowing companies to identify new drug targets, optimize clinical trials and speed delivery of medicines to patients.
Via
MarketBeat
Topics
Artificial Intelligence
Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday
↗
January 22, 2025
Via
Benzinga
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 22, 2025
From
Schrödinger
Via
Business Wire
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities
January 13, 2025
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 17, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
November 20, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 19, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Broadens and Accelerates Predictive Toxicology Initiative
November 18, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
↗
November 12, 2024
Schrödinger shares rise as they announce a research partnership and licensing agreement with Novartis AG. Schrödinger will receive $150 million upfront and eligible to receive up to approximately $2.3...
Via
Benzinga
Schrödinger Reports Third Quarter 2024 Financial Results
November 12, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis
November 12, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Present at Jefferies London Healthcare Conference
November 04, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Announce Third Quarter 2024 Financial Results on November 12
October 31, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium
October 23, 2024
From
Schrödinger
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit